SMTL ID : 4x69.2 (1 other biounit)

Crystal structure of OP0595 complexed with CTX-M-44

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.42 Å

Oligo State

monomer

Ligands

1 x OP0: (2S,5R)-N-(2-aminoethoxy)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide(Covalent)

OP0.1: 14 residues within 4Å: Chain A: C.43, S.44, K.47, N.78, Y.79, S.104, N.106, N.144, T.190, K.208, T.209, G.210, S.211, D.213 12 PLIP interactions: 12 interactions with chain A Hydrogen bonds: A:S.44, A:N.78, A:S.104, A:S.104, A:N.106, A:T.190, A:T.209, A:S.211, A:S.211 Water bridges: A:N.144, A:S.211 Salt bridges: A:K.208

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 8 residues within 4Å: Chain A: R.39, F.40, A.41, A.146, I.147, G.149, D.150, T.154 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:A.41, A:A.146, A:G.149 Water bridges: A:R.39, A:R.39, A:G.149, A:T.216

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Morinaka, A. et al., OP0595, a new diazabicyclooctane: mode of action as a serine beta-lactamase inhibitor, antibiotic and beta-lactam 'enhancer. J.Antimicrob.Chemother. (2015)

Release Date

2015-07-01

Peptides

Beta-lactamase Toho-1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Beta-lactamase Toho-1

Related Entries With Identical Sequence